Cho HI - Search Results

1

In vitro induction of carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes by dendritic cells transduced with recombinant adenoviruses.

Cho HI, Kim HJ, Oh ST, Kim TG. Cho HI, et al. Vaccine. 2003 Dec 12;22(2):224-36. doi: 10.1016/s0264-410x(03)00569-3. Vaccine. 2003. PMID: 14615150

2

Generation of Cytotoxic T Lymphocytes Specific for Human Cytomegalovirus Using Dendritic Cells In Vitro.

Cho HI, Han H, Kim CC, Kim TG. Cho HI, et al. J Immunother (1991). 2001 May;24(3):242-249. J Immunother (1991). 2001. PMID: 11395640

3

Efficient transduction with recombinant adenovirus in EBV-transformed B lymphoblastoid cell lines.

Kim HJ, Cho HI, Han YH, Park SY, Kim DW, Lee DG, Kim JH, Shin WS, Paik SY, Kim CC, Hong YS, Kim TG. Kim HJ, et al. Among authors: cho hi. J Biochem Mol Biol. 2004 May 31;37(3):376-82. doi: 10.5483/bmbrep.2004.37.3.376. J Biochem Mol Biol. 2004. PMID: 15469722

4

Dendritic cells transduced with recombinant adenoviruses induce more efficient anti-tumor immunity than dendritic cells pulsed with peptide.

Oh ST, Kim CH, Park MY, Won EH, Sohn HJ, Cho HI, Kang WK, Hong YK, Kim TG. Oh ST, et al. Among authors: cho hi. Vaccine. 2006 Apr 5;24(15):2860-8. doi: 10.1016/j.vaccine.2005.12.056. Epub 2006 Jan 13. Vaccine. 2006. PMID: 16443309

5

Enhanced induction of anti-tumor immunity in human and mouse by dendritic cells pulsed with recombinant TAT fused human survivin protein.

Cho HI, Kim EK, Park SY, Lee SK, Hong YK, Kim TG. Cho HI, et al. Cancer Lett. 2007 Dec 18;258(2):189-98. doi: 10.1016/j.canlet.2007.08.023. Epub 2007 Oct 10. Cancer Lett. 2007. PMID: 17931768

6

Efficient generation of survivin-specific cytotoxic T lymphocytes from healthy persons in vitro: quantitative and qualitative effects of CD4+ T cells.

Kim EK, Cho HI, Yoon SH, Park MJ, Sohn HJ, Kim HJ, Oh ST, Kim TG. Kim EK, et al. Among authors: cho hi. Vaccine. 2008 Jul 29;26(32):3987-97. doi: 10.1016/j.vaccine.2008.05.036. Epub 2008 Jun 6. Vaccine. 2008. PMID: 18584926

7

CD4 T-cells transduced with CD80 and 4-1BBL mRNA induce long-term CD8 T-cell responses resulting in potent antitumor effects.

Park HM, Sohn HJ, Kim YJ, Cho HI, Kim TG. Park HM, et al. Among authors: cho hi. Vaccine. 2014 Dec 5;32(51):6919-6926. doi: 10.1016/j.vaccine.2014.10.042. Epub 2014 Nov 3. Vaccine. 2014. PMID: 25444817

8

Zoledronic acid induces dose-dependent increase of antigen-specific CD8 T-cell responses in combination with peptide/poly-IC vaccine.

Park HM, Cho HI, Shin CA, Shon HJ, Kim TG. Park HM, et al. Among authors: cho hi. Vaccine. 2016 Mar 4;34(10):1275-81. doi: 10.1016/j.vaccine.2016.01.026. Epub 2016 Jan 29. Vaccine. 2016. PMID: 26828454

9

The clinical implications of mixed lymphocyte reaction with leukemic cells.

Kim HJ, Kim TG, Cho HI, Han H, Min WS, Kim CC. Kim HJ, et al. Among authors: cho hi. Int J Hematol. 2002 Nov;76(4):370-5. doi: 10.1007/BF02982699. Int J Hematol. 2002. PMID: 12463603

10

Humoral and cellular immune responses to influenza vaccine in patients with advanced cirrhosis.

Cheong HJ, Song JY, Park JW, Yeon JE, Byun KS, Lee CH, Cho HI, Kim TG, Kim WJ. Cheong HJ, et al. Among authors: cho hi. Vaccine. 2006 Mar 20;24(13):2417-22. doi: 10.1016/j.vaccine.2005.11.064. Epub 2005 Dec 19. Vaccine. 2006. PMID: 16406176

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

240 results

Search Page

Filters